Diabetic Eye Screening Programme
Estimated value
£11.6m
Awarded value
—
Suppliers
0
Lots
1
Published
18 May 2018
Description
The aim of the service is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, and population-based screening programmes that: - identify the eligible population and ensure effective delivery with maximum coverage; - are safe, effective, of a high quality, externally and independently monitored, and quality assured; - lead to earlier detection, appropriate referral, effective treatment and improved outcomes; - are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes; and - have audit embedded in the service. The contract term will be for an initial period of 3 years with the option to extend the contract by a further 24 Months at the discretion of the Commissioner and subject to satisfactory contractual and financial performance
Scope
- Reference
- MT212030
- Total value
- £11,589,593 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2019 to 31 Mar 2024
- CPV classifications
- 85100000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 20 Jun 2018, 11:00 pm